US 7618802 – SARS coronavirus

http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=PN/7618802

https://www.lens.org/lens/patent/123-391-283-167-215

Owner: the University of North Carolina, Chapel Hill

Inventors
On April 25, 2003, the United States Department of Health and Human Services Centers for Disease Control and Prevention (hereinafter, “CDC”) filed an application for a United States (Application Number US46592703P, subsequently issued as U.S. Patent 7,776,521) entitled “Coronavirus isolated from humans”.  Claim 3 –A method of detecting a severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in a sample…; and, Claim 4 – A kit for detecting a severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in a sample…, provided the CDC with a statutory market exclusion right the detection of and sampling for severe acute respiratory syndrome-associated coronavirus (SARS-CoV).  Securing this right afforded the CDC exclusive right to research, commercially exploit, or block others from conducting activities involving SARS-CoV. On September 24, 2018, the CDC failed to pay the required maintenance fees on this patent and their rights expired.

 

http://www.invertedalchemy.com/2020/04/covid-19-anti-trust-argument.html

Specializing in Pharmaceutical Technologies